Efficacy Study on the Lipid-lowering Effect of Plant Sterols and Fish Oil

NCT ID: NCT01313988

Last Updated: 2012-02-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

332 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Plant sterols and fish fatty acids are known to affect the blood lipid profile. This randomized, double-blind, placebo-controlled, parallel efficacy study is designed to investigate the lipid-lowering effect after 4 weeks intervention with the recommended dose of plant sterols and different doses of fish fatty acids when combined in a spread format.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Mildly Elevated Cholesterol Levels

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dose 1

Spread that contains plant sterols and fish oil

Group Type ACTIVE_COMPARATOR

Plant sterols and fish oil

Intervention Type DIETARY_SUPPLEMENT

4 weeks intervention, 3 times daily

Dose 2

Spread that contains plant sterols and fish oil

Group Type ACTIVE_COMPARATOR

Plant sterols and fish oil

Intervention Type DIETARY_SUPPLEMENT

4 weeks intervention, 3 times daily

Dose 3

Spread that contains plant sterols and fish oil

Group Type ACTIVE_COMPARATOR

Plant sterols and fish oil

Intervention Type DIETARY_SUPPLEMENT

4 weeks intervention, 3 times daily

Placebo

Placebo spread

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

4 weeks, 3 times daily

Control

Spread that contains plant sterols

Group Type ACTIVE_COMPARATOR

Plant sterols

Intervention Type DIETARY_SUPPLEMENT

4 weeks intervention, 3 times daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Plant sterols and fish oil

4 weeks intervention, 3 times daily

Intervention Type DIETARY_SUPPLEMENT

Plant sterols

4 weeks intervention, 3 times daily

Intervention Type DIETARY_SUPPLEMENT

Placebo

4 weeks, 3 times daily

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Apparently healthy men and women
* Age ≥ 25 and ≤ 75 years old
* Body mass index (BMI) ≥ 18 and ≤ 30 kg/m2
* Total cholesterol levels at screening ≥ 5.0 and ≤ 8.0 mmol/L
* 10-year CVD risk equal or lower than 10% according to "SCORE"
* Blood pressure, heart rate, hematological parameters, clinical chemical parameters within normal reference ranges
* Informed consent and biobank consent signed
* Willing to comply to study protocol during study
* Agreeing to be informed about medically relevant personal test-results by a physician
* Not smoking
* Accessible veins on the forearm
* Habitually consuming spreads

Exclusion Criteria

* Pregnant or having the wish to become pregnant, or lactating
* Use of prescribed medication which may interfere with study measurements
* Use of antibiotics in the 3 months before screening or during the study
* Use of any medically- or self-prescribed diet with the purpose to reduce weight
* Intolerance for gluten or lactose
* Reported food allergy
* Having bleeding disorders
* Recent blood donation
* Excessive alcohol consumption
* Strenuous exercise
* Reported weight change ≥ 10 % of body weight or use of prescribed weight reduction drugs
* Recent participation in another nutritional or medical trial
* Participation in night shift work
Minimum Eligible Age

25 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Unilever R&D

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Johan Olsson, PhD

Role: PRINCIPAL_INVESTIGATOR

KPL Good Food Practice AB

Birgitta Sundberg, PhD

Role: STUDY_DIRECTOR

KPL Good Food Practice AB

Anneli Hallmin

Role: STUDY_DIRECTOR

KPL Good Food Practice AB

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

KPL Good Food Practice AB

Uppsala, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Ras RT, Demonty I, Zebregs YE, Quadt JF, Olsson J, Trautwein EA. Low doses of eicosapentaenoic acid and docosahexaenoic acid from fish oil dose-dependently decrease serum triglyceride concentrations in the presence of plant sterols in hypercholesterolemic men and women. J Nutr. 2014 Oct;144(10):1564-70. doi: 10.3945/jn.114.192229. Epub 2014 Aug 13.

Reference Type DERIVED
PMID: 25122648 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10018V

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Genotype-related Effects of PUFA
NCT02296385 COMPLETED NA